Persistent Hypersomnolence Following Aneurysmal Subarachnoid Hemorrhage: A Case Report
Abstract
Persistent excessive daytime sleepiness (EDS) following aneurysmal subarachnoid hemorrhage (SAH) is an underrecognized complication that may impair quality of life and patient safety. We report a 60-year-old man with EDS that had been present for approximately one year and progressively worsened following aneurysmal SAH despite adequately treated obstructive sleep apnea. Overnight polysomnography (PSG) demonstrated well-controlled sleep-disordered breathing, while the multiple sleep latency test (MSLT) revealed severe objective hypersomnolence, supporting a diagnosis of secondary central hypersomnia. Alternative causes of EDS were excluded through clinical evaluation and objective sleep testing. The patient experienced meaningful improvement following treatment with modafinil. This case highlights the importance of considering secondary central hypersomnia in patients with persistent EDS after aneurysmal SAH. It demonstrates the value of PSG followed by MSLT in establishing the diagnosis and guiding management.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.